ClairLabs offers Impactomics, an AI-powered NGS platform that ingests next‑generation sequencing data to automate analysis, interpret results, and surface actionable genomics insights. Presented as a live, production-ready SaaS/cloud product, it targets professional genomics users—clinical laboratories, research institutes, biotech/pharma and diagnostics enterprises—and emphasizes demo-driven B2B engagement via lead-capture forms. The site highlights conference presence and social outreach, stresses consent/privacy for regulated data, and positions the company as an AI-first alternative to traditional NGS interpretation with an enterprise sales focus.